DT-9081
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DT-9081, covering 2025-08-28 to 2025-08-28. Get the full timeline:
Most recent: Clinical Trial Update: DT-9081 Study in Participants With Advanced, Recurrent or Metastatic Solid Tumours [Phase 1]